The key GLP-1 interactions are: low blood sugar when combined with insulin or sulfonylureas; reduced absorption of some oral medicines because GLP-1s slow gastric emptying — tirzepatide's label specifically notes reduced effectiveness of oral contraceptives; and a higher aspiration risk under anaesthesia, so your surgical team may advise holding a dose before a procedure. Alcohol can compound stomach upset and low-blood-sugar risk. Always give your clinician and pharmacist your full medication list.
Key takeaways
- With insulin or sulfonylureas, GLP-1s raise the risk of hypoglycemia — those doses may be reduced.
- Slowed gastric emptying can change how oral medicines are absorbed.
- Tirzepatide can reduce oral contraceptive effectiveness; a backup or non-oral method is advised when starting or increasing the dose.
- Tell your surgeon and anaesthetist you take a GLP-1 — they may advise holding a dose before surgery.
- Alcohol can add to GI effects and low-blood-sugar risk.
Low blood sugar with insulin and sulfonylureas
On their own, GLP-1 receptor agonists carry a relatively low risk of hypoglycemia because they help regulate insulin in a glucose-dependent way. The picture changes when they are combined with medicines that lower blood sugar more forcefully — namely insulin and sulfonylureas (for example glipizide, glimepiride, glyburide). Stacking these can push blood sugar too low.
This is why a clinician will often reduce the dose of insulin or a sulfonylurea when you start or increase a GLP-1. If you take those combinations, it's worth knowing the symptoms of low blood sugar — shakiness, sweating, a racing heart, confusion, irritability — and how to treat it quickly with fast-acting carbohydrate. Our dosing guide explains why doses are stepped up gradually, which also helps your care team adjust other medicines safely.
Absorption: why slowed emptying matters
GLP-1s work partly by slowing gastric emptying — the same mechanism behind the appetite and fullness effects covered in our side-effects guide. A slower-emptying stomach can change how quickly and how completely some oral medicines are absorbed. For most drugs this is not clinically significant, but it's the reason the topic comes up, and it's the basis of the contraceptive interaction below.
Birth control and tirzepatide
This one is specific and important. Tirzepatide's prescribing information notes that it can reduce the effectiveness of oral contraceptives, likely because of that slowed gastric emptying. The label advises using a backup method of contraception — or switching to a non-oral method — when you start tirzepatide and for a period after each dose increase.
If you rely on the pill and are starting tirzepatide (sold as Zepbound and Mounjaro), this is a direct conversation to have with your clinician. The exact guidance depends on your specific medication, so don't assume — ask.
GLP-1 interactions at a glance
| Interaction | Why it happens | What it usually means |
|---|---|---|
| Insulin + GLP-1 | Additive blood-sugar lowering | Risk of hypoglycemia; insulin dose may be reduced |
| Sulfonylureas + GLP-1 | Additive blood-sugar lowering | Risk of hypoglycemia; dose may be reduced |
| Oral contraceptives + tirzepatide | Slowed gastric emptying affects absorption | Use backup or non-oral method when starting/increasing |
| Other oral medicines | Slowed gastric emptying | Usually minor; review with your pharmacist |
| Anaesthesia / surgery | Delayed emptying raises aspiration risk | Team may advise holding a dose before a procedure |
| Alcohol | Compounds GI upset and low-blood-sugar risk | Use caution, especially early on |
Before surgery: tell your anaesthesia team
Because GLP-1s slow how quickly the stomach empties, food and fluid can remain in the stomach longer than expected — which raises the risk of aspiration (stomach contents entering the lungs) during anaesthesia. For that reason, your surgical and anaesthesia team needs to know you take a GLP-1.
Alcohol and everyday combinations
Alcohol doesn't have a single dramatic interaction with GLP-1s, but it can compound the gastrointestinal effects — nausea, upset stomach — and, particularly if you also take insulin or a sulfonylurea, add to the risk of low blood sugar. Going easy on alcohol, especially in the early weeks and after dose increases, is sensible. And as always, individual guidance comes from your clinician and pharmacist, who can look at your full regimen. GLP-1s are increasingly studied for a range of conditions — see our page on other uses of GLP-1s — but the interaction principles here apply regardless of why the drug was prescribed.
Frequently asked questions
What drugs interact with GLP-1s?
The most important interactions involve other diabetes medicines and oral drugs whose absorption can change. Combined with insulin or sulfonylureas, GLP-1s raise the risk of low blood sugar. Because GLP-1s slow gastric emptying, they can affect how some oral medicines are absorbed — tirzepatide's label notes reduced effectiveness of oral contraceptives. Alcohol can add to gastrointestinal upset and low-blood-sugar risk. Always give your clinician and pharmacist your full medication list.
Can GLP-1s cause low blood sugar?
On their own, GLP-1s carry a relatively low risk of hypoglycemia. But when combined with insulin or a sulfonylurea, the risk of low blood sugar goes up. A clinician may lower the dose of those other medicines when you start or increase a GLP-1. Know the symptoms of hypoglycemia — shakiness, sweating, confusion — and how to treat it if you take those combinations.
Do GLP-1s affect birth control?
Tirzepatide's prescribing information notes that it can reduce the effectiveness of oral contraceptives, likely because slowed gastric emptying affects absorption. The label advises using a backup method of contraception or switching to a non-oral method when starting tirzepatide and for a period after each dose increase. If you rely on the pill, ask your clinician what applies to your specific medication.
Do I need to stop my GLP-1 before surgery?
Because GLP-1s slow gastric emptying, they can raise the risk of aspiration under anaesthesia. Tell your surgical and anaesthesia team that you take a GLP-1; they may advise holding a dose before a scheduled procedure. Do not stop or change your dose on your own — follow the guidance your care team gives for your situation.
Sources & further reading
- U.S. Food & Drug Administration — prescribing information for semaglutide and tirzepatide products, including Drug Interactions and Warnings and Precautions sections.
- U.S. Food & Drug Administration — tirzepatide label note on reduced oral contraceptive effectiveness.
- Professional anaesthesia society guidance on perioperative management of GLP-1 receptor agonists.